贵州医药制造企业市场竞争力研究
发布时间:2018-03-14 11:23
本文选题:贵州 切入点:医药制造企业 出处:《贵州大学》2014年硕士论文 论文类型:学位论文
【摘要】:随着我国经济对外开放的进一步发展,国外众多医药制造企业开始进入我国市场,国内医药制造企业面临着国内外双重竞争压力。贵州经济发展正处于高速发展时期,而医药制造业作为贵州的重点产业之一,要及时抓住发展机遇,提高市场竞争能力。本研究先从贵州医药制造企业发展的背景出发,得出其提高市场竞争力的必要性;然后对医药产业、医药制造企业以及市场竞争力的相关研究进行理论研究。在相关理论的研究基础上,搜集相关的统计数据;运用比较分析、规范分析、定性与定量分析等相关方法;结合贵州医药产业发展政策,,从研发能力、市场竞争能力等构成要素方面;分析贵州医药制造企业发展的现状。在综合理论、现状分析的基础上,结合国内外关于医药制造行业或企业市场竞争力相关研究论述;构建出贵州医药制造企业市场竞争力评价指标体系。进一步运用因子分析、主成分分析等实证方法,搜集相关的数据,对贵州医药制造企业的市场竞争力作实证研究。对贵州医药制造企业从2005年——2012年近8年的发展状况作市场竞争力动态分析;取2011年较为完整的截面数据作总体评价研究;分别对中成药生产企业、中药饮片加工企业、化学药品制剂制造企业、生物药品制造企业以及贵州医药制造龙头企业市场竞争力进行分析。最后在实证分析结论的基础上,结合相关理论以及发展现状,从研发资金获取、企业自主创新能力、知识产权保护、营销组合策略、创新网络等角度提出提升贵州医药制造企业市场竞争力的对策建议。
[Abstract]:With the further development of China's economic opening to the outside world, many foreign pharmaceutical manufacturing enterprises have begun to enter the Chinese market, and domestic pharmaceutical manufacturing enterprises are facing double competitive pressures at home and abroad. The economic development of Guizhou is in a period of rapid development. As one of the key industries in Guizhou, the pharmaceutical manufacturing industry should seize the development opportunity in time and improve the market competition ability. Firstly, this study starts from the background of the development of Guizhou pharmaceutical manufacturing enterprises and finds out the necessity of improving the market competitiveness. Then the relevant research on pharmaceutical industry, pharmaceutical manufacturing enterprises and market competitiveness is carried out theoretically. On the basis of relevant theoretical research, relevant statistical data are collected, and comparative analysis is used to standardize the analysis. Qualitative and quantitative analysis and other relevant methods; combined with Guizhou pharmaceutical industry development policy, from the research and development ability, market competitiveness and other elements; analysis of the current situation of Guizhou pharmaceutical manufacturing enterprises. On the basis of comprehensive theory, current situation analysis, Combined with domestic and international research on the market competitiveness of pharmaceutical manufacturing industry or enterprises, the paper constructs the evaluation index system of Guizhou pharmaceutical manufacturing enterprises' market competitiveness, and further uses empirical methods such as factor analysis, principal component analysis, etc. To collect relevant data, to make an empirical study on the market competitiveness of Guizhou pharmaceutical manufacturing enterprises, and to make a dynamic analysis of the market competitiveness of Guizhou pharmaceutical manufacturing enterprises during the past eight years from 2005 to 2012. Taking the complete cross-section data of 2011 as the overall evaluation research, respectively, to the Chinese patent medicine production enterprises, the Chinese medicine pieces processing enterprises, the chemical drug preparation manufacturing enterprises, The market competitiveness of biopharmaceutical manufacturing enterprises and Guizhou leading pharmaceutical manufacturing enterprises is analyzed. Finally, on the basis of empirical analysis conclusion, combining with relevant theories and development status, we obtain R & D funds and enterprises' independent innovation ability. From the aspects of intellectual property protection, marketing combination strategy, innovation network and so on, the countermeasures and suggestions are put forward to enhance the market competitiveness of Guizhou pharmaceutical manufacturing enterprises.
【学位授予单位】:贵州大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:F426.72;F271
【参考文献】
相关期刊论文 前10条
1 刘程惠;胡文忠;何煜波;姜爱丽;徐国凯;;中华民族医药——蒙药的发展历史与研究进展[J];安徽农业科学;2012年22期
2 孙杰,张锐,许陶;经济全球化背景下的中国医药产业的发展策略[J];商业研究;2005年04期
3 冯英娟;邹明;;吉林省医药产业竞争力提升对策研究[J];长春理工大学学报(社会科学版);2012年07期
4 李海舰,聂辉华;企业的竞争优势来源及其战略选择[J];中国工业经济;2002年09期
5 刘野;钱欣;;基于主成分分析的贵州医药行业竞争力分析及经营绩效评价[J];经营管理者;2010年20期
6 姚霞;;推进我国医药行业兼并重组的政策选择[J];中国医药科学;2013年18期
7 吴淑艳;;科技型企业核心竞争力的培育与构建[J];产业与科技论坛;2014年01期
8 张化尧;李德扬;;我国医药制造业低创新能力原因分析[J];经济论坛;2012年02期
9 陈春发;朱意;;中国医药制造企业盈利能力与影响因素的实证研究[J];经济体制改革;2008年03期
10 王东梅;张金隆;;湖北省医药产业发展的现状及对策分析[J];科技进步与对策;2008年12期
本文编号:1611011
本文链接:https://www.wllwen.com/falvlunwen/zhishichanquanfa/1611011.html